To use all functions of this page, please activate cookies in your browser.
My watch list
my.bionity.com
my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Last viewed
- Results of Phase III Bravo trial reinforce unique profile of laquinimod for multiple sclerosis treatment - Primary endpoint of reducing annualized relapse rate was not statistically achieved
- Immunoglobulin_G
- Schizosaccharomyces_pombe
- Searching for more - The hunt for diversification, multimodal approaches and top talent are rapidly reshaping life sciences
